Feb 13, 2019 - Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $20.1 million of Shares, Stocks: VRTX, release date:Feb 13, 2019
Feb 11, 2019 - Vertex Pharmaceuticals showed a 40% revenue increase from a year ago.A larger patient base boosted profits on the company's three approved CF medications.VRTX share prices have doubled in the last two
Feb 07, 2019 - The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO
Feb 06, 2019 - Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $6 million of Shares, Stocks: VRTX, release date:Feb 06, 2019
Feb 06, 2019 - Vertex's (VRTX) Q4 grows on earnings and revenue beat with rising demand for its CF products. Shares up.
Feb 06, 2019 - Key highlights of the week were the fourth-quarter results by biotech bigwigs Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX) and Celgene (CELG).
Feb 06, 2019 -
Feb 05, 2019 - The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2018 Q4 earnings call.
Feb 05, 2019 -
Feb 04, 2019 - Strong Eylea and Dupixent sales are likely to propel better-than-expected results for Regeneron (REGN) when it reports fourth-quarter results.